MOVE OVER MS Trademark

Trademark Overview

On Monday, January 25, 2021, a trademark application was filed for MOVE OVER MS with the United States Patent and Trademark Office. The USPTO has given the MOVE OVER MS trademark a serial number of 90485613. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Tuesday, October 17, 2023. This trademark is owned by Acorda Therapeutics, Inc.. The MOVE OVER MS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical products, namely, pharmaceutical and biological preparations used in the treatment of spinal cord injuries, multiple sclerosis and other diseases, disorders or conditions of the nervous system
move over ms

General Information

Serial Number90485613
Word MarkMOVE OVER MS
Filing DateMonday, January 25, 2021
Status733 - FOURTH EXTENSION - GRANTED
Status DateTuesday, October 17, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 24, 2021

Trademark Statements

Goods and ServicesPharmaceutical products, namely, pharmaceutical and biological preparations used in the treatment of spinal cord injuries, multiple sclerosis and other diseases, disorders or conditions of the nervous system

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, April 10, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAcorda Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressPearl River, NY 10965
Party NameAcorda Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressArdsley, NY 10502

Trademark Events

Event DateEvent Description
Thursday, October 19, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 17, 2023SOU EXTENSION 4 GRANTED
Tuesday, October 17, 2023SOU EXTENSION 4 FILED
Tuesday, October 17, 2023SOU TEAS EXTENSION RECEIVED
Saturday, April 15, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 13, 2023SOU EXTENSION 3 GRANTED
Thursday, April 13, 2023SOU EXTENSION 3 FILED
Thursday, April 13, 2023SOU TEAS EXTENSION RECEIVED
Thursday, October 6, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 4, 2022SOU EXTENSION 2 GRANTED
Tuesday, October 4, 2022SOU EXTENSION 2 FILED
Tuesday, October 4, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, April 13, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 11, 2022SOU EXTENSION 1 GRANTED
Monday, April 11, 2022SOU EXTENSION 1 FILED
Monday, April 11, 2022SOU TEAS EXTENSION RECEIVED
Thursday, December 2, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, December 2, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, December 2, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, December 2, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, December 2, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, October 19, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 24, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 24, 2021PUBLISHED FOR OPPOSITION
Wednesday, August 4, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, July 21, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 21, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, July 21, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, July 21, 2021ASSIGNED TO LIE
Friday, July 2, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, May 14, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, May 14, 2021NON-FINAL ACTION E-MAILED
Friday, May 14, 2021NON-FINAL ACTION WRITTEN
Friday, May 7, 2021ASSIGNED TO EXAMINER
Saturday, April 10, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, January 28, 2021NEW APPLICATION ENTERED

Related Keywords

over move pharmaceutical other sclerosis diseases disorders system nervous conditions multiple cord